MRWM
ABBV icon

ML&R Wealth Management’s AbbVie ABBV Stock Holding History

ML&R Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$375K Hold
2,060
– – 0.09% 51
2023
Q4 		$319K Sell
2,060
-39
-2% -$5.69K 0.07% 60
2023
Q3 		$313K Sell
2,099
-23,990
-92% -$3.52M 0.08% 52
2023
Q2 		$3.51M Buy
26,089
+24,283
+1,345% +$3.56M 0.78% 18
2023
Q1 		$288K Buy
+1,806
New +$276K 0.08% 53

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

ML&R Wealth Management's ABBV Position: Q1 2024 in Review

ML&R Wealth Management held its AbbVie (ABBV) position steady in Q1 2024 at 2,060 shares worth $375K. The position accounts for 0.09% of the portfolio, ranked #51.

ML&R Wealth Management first reported a position in ABBV in Q1 2023 and has held it in 5 quarters since. The position peaked at $3.51M in Q2 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • ML&R Wealth Management held 2,060 shares of AbbVie worth $375K as of Q1 2024.
  • ML&R Wealth Management left its AbbVie share count unchanged in Q1 2024.
  • AbbVie made up 0.09% of ML&R Wealth Management's portfolio in Q1 2024, its #51 holding.
  • ML&R Wealth Management first reported a position in AbbVie in Q1 2023 and has held it in 5 quarters since.
  • ML&R Wealth Management's AbbVie position peaked at $3.51M in Q2 2023.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on ML&R Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.